IL96368A0 - Protein complexes having factor viii:c activity,their production,and pharmaceutical compositions containing them - Google Patents

Protein complexes having factor viii:c activity,their production,and pharmaceutical compositions containing them

Info

Publication number
IL96368A0
IL96368A0 IL96368A IL9636890A IL96368A0 IL 96368 A0 IL96368 A0 IL 96368A0 IL 96368 A IL96368 A IL 96368A IL 9636890 A IL9636890 A IL 9636890A IL 96368 A0 IL96368 A0 IL 96368A0
Authority
IL
Israel
Prior art keywords
factor viii
human factor
activity
domain
polypeptide
Prior art date
Application number
IL96368A
Other languages
English (en)
Original Assignee
Chiron Corp
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp, Novo Nordisk As filed Critical Chiron Corp
Publication of IL96368A0 publication Critical patent/IL96368A0/xx
Priority to IL11130494A priority Critical patent/IL111304A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
IL96368A 1989-11-17 1990-11-16 Protein complexes having factor viii:c activity,their production,and pharmaceutical compositions containing them IL96368A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL11130494A IL111304A0 (en) 1989-11-17 1994-10-14 Protein complexes having factor VIII:C activity and their production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43863989A 1989-11-17 1989-11-17

Publications (1)

Publication Number Publication Date
IL96368A0 true IL96368A0 (en) 1991-08-16

Family

ID=23741420

Family Applications (2)

Application Number Title Priority Date Filing Date
IL96368A IL96368A0 (en) 1989-11-17 1990-11-16 Protein complexes having factor viii:c activity,their production,and pharmaceutical compositions containing them
IL11130494A IL111304A0 (en) 1989-11-17 1994-10-14 Protein complexes having factor VIII:C activity and their production

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL11130494A IL111304A0 (en) 1989-11-17 1994-10-14 Protein complexes having factor VIII:C activity and their production

Country Status (22)

Country Link
EP (2) EP0500734B1 (pt)
JP (3) JP2865861B2 (pt)
KR (2) KR960701899A (pt)
AT (1) ATE163194T1 (pt)
AU (1) AU656311B2 (pt)
CA (2) CA2135744A1 (pt)
DE (1) DE69032043T2 (pt)
DK (1) DK0500734T3 (pt)
ES (1) ES2112255T3 (pt)
FI (2) FI922204A0 (pt)
GR (1) GR3026176T3 (pt)
HU (2) HUT64591A (pt)
IE (1) IE904140A1 (pt)
IL (2) IL96368A0 (pt)
NO (2) NO921946L (pt)
NZ (1) NZ236094A (pt)
PL (1) PL167083B1 (pt)
PT (1) PT95923B (pt)
SK (1) SK130194A3 (pt)
WO (1) WO1991007490A1 (pt)
YU (2) YU218690A (pt)
ZA (1) ZA909167B (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE465222C5 (sv) * 1989-12-15 1998-02-10 Pharmacia & Upjohn Ab Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
US5326700A (en) * 1990-11-06 1994-07-05 Eli Lilly And Company DNA sequences encoding t-PA derivatives with cleavable sites
SE468050C (sv) * 1991-03-15 1998-04-27 Pharmacia & Upjohn Ab Rekombinant derivat av human faktor VIII
CA2078721A1 (en) * 1991-09-24 1993-03-25 Hiroshi Yonemura Process for preparing human coagulation factor viii protein complex
DK53792D0 (da) * 1992-04-24 1992-04-24 Novo Nordisk As Fremgangsmaade til fremstilling af proteiner
KR100234828B1 (ko) * 1995-10-16 1999-12-15 카나가와 치히로 액정조성물 및 이를 함유하는 액정표시소자
ATE319817T1 (de) 1996-04-24 2006-03-15 Univ Michigan Gegen inaktivierung resistenter faktor viii
US8183344B2 (en) 1996-04-24 2012-05-22 University Of Michigan Inactivation resistant factor VIII
GB2318732A (en) 1996-11-01 1998-05-06 Johnson & Johnson Medical Wound healing compositions containing alpha-1-antitrypsin
US6200560B1 (en) 1998-10-20 2001-03-13 Avigen, Inc. Adeno-associated virus vectors for expression of factor VIII by target cells
US6221349B1 (en) 1998-10-20 2001-04-24 Avigen, Inc. Adeno-associated vectors for expression of factor VIII by target cells
SK287706B6 (en) * 2000-03-22 2011-07-06 Octapharma Biopharmaceuticals Gmbh Production of recombinant blood clotting factors in human cell lines
DK3211085T3 (da) 2003-09-30 2021-06-21 Univ Pennsylvania Klader af adeno-associeret virus (aav), sekvenser, vektorer indeholdende disse og anvendelser deraf
EP1707634A1 (en) 2005-03-29 2006-10-04 Octapharma AG Method for isolation of recombinantly produced proteins
CN102994549B (zh) 2005-04-07 2015-02-11 宾夕法尼亚大学托管会 增强腺相关病毒载体功能的方法
EP1739179A1 (en) 2005-06-30 2007-01-03 Octapharma AG Serum-free stable transfection and production of recombinant human proteins in human cell lines
WO2011095604A1 (en) 2010-02-04 2011-08-11 Octapharma Biopharmaceuticals Gmbh Half-life prolongation of proteins
US9315825B2 (en) 2010-03-29 2016-04-19 The Trustees Of The University Of Pennsylvania Pharmacologically induced transgene ablation system
KR20130040844A (ko) 2010-03-29 2013-04-24 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 약학적으로 유발된 전이유전자 제거 시스템
CN103502458B (zh) 2011-02-17 2016-11-16 宾夕法尼亚大学托管会 用于改变组织特异性和改善aav9-介导的基因转移的组合物和方法
WO2015012924A2 (en) 2013-04-29 2015-01-29 The Trustees Of The University Of Pennsylvania Tissue preferential codon modified expression cassettes, vectors containing same, and use thereof
CN108093639B (zh) 2015-04-16 2022-07-19 埃默里大学 用于肝脏中蛋白质表达的重组启动子和载体及其用途
KR20230042754A (ko) 2020-08-07 2023-03-29 아미쿠스 세라퓨틱스, 인코포레이티드 소포 표적화 단백질 및 이의 용도

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652530A (en) 1967-08-28 1972-03-28 American Nat Red Cross Antihemophilic factor prepared from blood plasma using polyethylene glycol
US3631018A (en) 1970-05-01 1971-12-28 Baxter Laboratories Inc Production of stable high-potency human ahf using polyethylene glycol and glycine to fractionate a cryoprecipitate of ahf concentrate
US4069216A (en) 1975-06-16 1978-01-17 Edward Shanbrom, Inc. Simplified methods for preparation of very high purity Factor VIII concentrate
AU577259B2 (en) * 1982-08-13 1988-09-22 Zymogenetics Inc. Glycolytic promters for regulated protein expression protease inhibitor
JPH07106156B2 (ja) * 1983-10-28 1995-11-15 ジェネティックス、インスティチュ−ト ファクタ−▲ｖｉｉｉ▼および関連生産物の製造
CA1341174C (en) * 1985-04-12 2001-01-30 John J. Toole Jr. Procoagulant proteins derived from factor viii: c
FI98829C (fi) * 1986-01-27 1997-08-25 Chiron Corp Menetelmä rekombinoidun proteiinikompleksin valmistamiseksi, jolla on humaanitekijä VIII:C-aktiivisuutta
AU588965B2 (en) * 1986-02-06 1989-09-28 Alcatel Australia Limited Telephone hook-switch

Also Published As

Publication number Publication date
PL167083B1 (pl) 1995-07-31
PL287807A1 (en) 1991-09-23
HU9201629D0 (en) 1992-08-28
NO921946L (no) 1992-07-13
ATE163194T1 (de) 1998-02-15
CA2068728A1 (en) 1991-05-18
DK0500734T3 (da) 1998-03-30
JPH11130800A (ja) 1999-05-18
CA2135744A1 (en) 1991-05-18
FI922204L (fi) 1992-05-14
HUT64591A (en) 1994-01-28
IL111304A0 (en) 1994-12-29
JP2865861B2 (ja) 1999-03-08
WO1991007490A1 (en) 1991-05-30
FI944903L (fi) 1994-10-19
FI944903A0 (fi) 1994-10-19
NZ236094A (en) 1993-04-28
ES2112255T3 (es) 1998-04-01
PT95923B (pt) 1998-04-30
KR960701899A (ko) 1996-03-28
NO943949L (no) 1992-07-13
ZA909167B (en) 1993-10-15
PT95923A (pt) 1991-09-13
GR3026176T3 (en) 1998-05-29
KR927003812A (ko) 1992-12-18
EP0500734B1 (en) 1998-02-11
YU78194A (sh) 1997-05-28
SK130194A3 (en) 1997-06-04
JPH0856656A (ja) 1996-03-05
EP0500734A1 (en) 1992-09-02
AU6752590A (en) 1991-06-13
YU218690A (sh) 1993-05-28
NO943949D0 (no) 1994-10-18
FI922204A7 (fi) 1992-05-14
IE904140A1 (en) 1991-05-22
FI944903A7 (fi) 1994-10-19
NO921946D0 (no) 1992-05-15
EP0670332A3 (en) 1995-10-25
HU9500546D0 (en) 1995-04-28
HUT70457A (en) 1995-10-30
JP2771129B2 (ja) 1998-07-02
DE69032043T2 (de) 1998-06-04
FI922204A0 (fi) 1992-05-14
EP0670332A2 (en) 1995-09-06
AU656311B2 (en) 1995-02-02
JPH05502025A (ja) 1993-04-15
DE69032043D1 (de) 1998-03-19

Similar Documents

Publication Publication Date Title
IL96368A0 (en) Protein complexes having factor viii:c activity,their production,and pharmaceutical compositions containing them
ES8307297A1 (es) Proceso para la produccion microbiana de interferon fibro- blasto humano
AU4067985A (en) Hosts and methods for producing recombinant products in high yields
NZ233642A (en) Linked hemoglobin subunits, preparation by genetic engineering and linker assay
DE69131580D1 (de) GDF-1 und UOG1 Proteine
DE69836956D1 (de) Rezeptor 5, der eine für den zelltod verantwortliche domäne enthält
DE69637874D1 (de) C-C CHEMOKIN REZEPTOR 3: CKR-3 ODER Eos-L2
DE69333346T2 (de) Neuartiges p- selectin ligandenprotein
DE60039677D1 (de) Akt-3 nukleinsäure, polypeptide und deren verwendung
JPH02502825A (ja) 好中球活性化因子
CA2032167A1 (en) Dna coding for protein binds to enhancer of.alpha.-fetoprotein gene
ATE295890T1 (de) Vektor zur expression von n-terminal verlängerten proteinen in hefezellen
EP0276778A3 (en) High level expression in e. coli of soluble mature hil-1beta and derivatives with altered biological activity
DK0414151T3 (da) Humane nervevæskstfaktorproteiner og fremstilling deraf
WO2001079525A3 (en) Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
RU92004585A (ru) Промотор, днк-последовательность, вектор, клетки, способ экспрессии днк
GR3024625T3 (es) Calcium-regulated promoter